For fourth-quarter 2008, the Company
recorded reported revenues of $12.3 list of antibiotics for respiratory infection billion, a decrease of 4% compared
with the year-ago quarter. Zyrtec, Camptosar antibiotic valacyclovir∞

and Norvasc fourth-quarter 2008 will azithromycin treat pilonidal cyst
revenues decreased by $515 million ($263 million, amoxycillin∞

$144 million and $108
million, respectively), compared with the year-ago quarter. PFE - about antibiotics cilicaine vk 500 mg News) today reported financial results for
fourth-quarter and full-year 2008.

For fourth-quarter 2008, Pfizer posted. This decrease was primarily attributable to
the negative drugstore∞

impact of the loss of U.S. Reported revenues accounted for 43% of the total compared with 44% in
the year-ago quarter, while international reported list of antibiotics in the philippines revenues accounted
for 57% of the total compared with 56% in the year-ago quarter.

Exclusivity for Zyrtec in
and for Camptosar in as well as the loss zithromax∞

of
exclusivity for Norvasc in aquaticure doxycycline antibiotic Korea and Japan in and July
2008, respectively. International
reported valacyclovir∞

revenues for cut lip is antiviral or antibiotic i were $7.1 billion, a decrease of 1% compared with the
year-ago quarter, and reflect antibiotic∞

operational growth of 5%, which was more
than offset by the unfavorable impact triple antibiotic ointment msds msd of azythromycin foreign exchange of 6%. Reported revenues antibiotic∞

were $5.3 billion in fourth-quarter 2008, a
decrease of 8% compared with the zithromax year-ago quarter. In addition, amoxicillin with tk
foreign exchange unfavorably impacted reported revenues by approximately
$380 million or 3%, partially offset by the solid performance generic cipralex∞

of key
products. ($ in millions, except per share triple antibiotic ointment and cold sores sore amounts)




Fourth-Quarter





Full-Year




2008





2007





Change




2008





2007



is hair loss a side effect of the antibiotic cipro

Change


Reported Revenues


tetracycline∞

$ 12,346




$ 12,870




(4%)




$ 48,296




$ 48,418




--


Reported Net Income


266




2,724
will azithromycin treat impetigo azithromycin



(90%)




8,104




8,144




--


Reported Diluted EPS


0.04




0.40




(90%)




1.20




1.17




3%


Adjusted Revenues(1)

12,311


triple antibiotic ointment on genital herpes herpe

12,795




(4%)




48,341




48,209




--


Adjusted Income(1)

4,389


cilicaine antibiotic

3,402




29%




16,366
tetanus shot contain antibiotics



15,113




8%


Adjusted Diluted EPS(1)

0.65




0.50




30%




2.42




2.18




11%




























See end of text prior to tables for notes. NEW YORK-- --Pfizer Inc (NYSE.